Brain activation of monocyte-lineage cells: Involvement of interleukin-6

NeuroImmunoModulation

Volumn 10, Issue 5, 2002, Pages 295-304

  Shafer, Lisa L ^a   McNulty, John A ^a   Young, M Rita I ^a,b  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^b HINES VA HOSPITAL   (United States)

Author keywords

Brain injury; MHC II expression; Phagocytosis

Indexed keywords

INTERLEUKIN 6; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; IMMUNE RESPONSE; MICROGLIA; MONOCYTE; MORPHOLOGY; MOUSE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

ANIMALS; BRAIN INJURIES; CELL LINEAGE; CELL SHAPE; CELLS, CULTURED; CHEMOTAXIS, LEUKOCYTE; COCULTURE TECHNIQUES; DOWN-REGULATION; ENCEPHALITIS; FEMALE; GLIOSIS; HISTOCOMPATIBILITY ANTIGENS CLASS II; INTERLEUKIN-6; MACROPHAGES; MICE; MICE, INBRED C57BL; MICROGLIA; MONOCYTES; ORGAN CULTURE TECHNIQUES; PHAGOCYTOSIS; UP-REGULATION;

EID: 0038017110     PISSN: 10217401     EISSN: None     Source Type: Journal    
DOI: 10.1159/000069973     Document Type: Article

References (63)

1. Gadient RA, Otten UH: Interleukin-6 (IL-6) - a molecule with both beneficial and destructive potentials. Prog Neurobiol 1997;52:379-390.
2. Benveniste EN, Tang LP, Law RM: Differential regulation of astrocyte TNF-alpha expression by the cytokines TGF-beta, Il-6 and IL-10. Int J Dev Neurosci 1995;13:341-349.
3. Kossmann T, Hans VHJ, Imhof HG, Stocker T, Grob P, Trentz O, Morganti-Kossmann: In-trathecal and serum interleukin 6 and the acute-phase response in patients with severe traumatic brain injuries. Shock 1995;5:311-317.
4. Heesen M, Deinsberger W, Dietrich GV, Detsch O, Boldt J, Hempelmann G: Increase of interleukin-6 plasma levels after elective craniotomy: Influence of interleukin-10 and catecholamines. Acta Neurochir 1996;138:77-80.
5. Righi M, Mori L, de Libero G: Monokine production by microglial cell clones. Eur J Immunol 1989;19:1443-1448.
6. Sawada M, Suzumura A, Marunouchi T: TNF-alpha induces IL-6 production by astrocytes but not by microglia. Brain Res 1992;583:296-299.
7. Ringheim GE, Burgher KL, Heroux JA: Interleukin-6 mRNA expression by cortical neurons in culture: Evidence for neuronal sources of interleukin-6 production in the brain. J Neuroimmunol 1995;63:113-123.
8. Hopkins SJ, Rothwell NJ: Cytokines and the nervous system. I. Expression and recognition. Trends Neurosci 1995;18:83-88.
9. Woodroofe MN, Sarna GS, Wadhwa M, Hayes GM, Loughlin AJ, Tinker A, Cuzner ML: Detection of interleukin-1 and interleukin-6 in adult rat brain, following mechanical injury, by in vivo microdialysis: Evidence of a role of microglia in cytokine production. J Neuroimmunol 1991;33:227-236.
10. Gruol DL, Nelson TE: Physiological and pathological roles of interleukin-6 in the central nervous system. Mol Neurobiol 1997;15:307-339.
11. Van Wagoner NJ, Benveniste EN: Interleukin-6 expression and regulation in astrocytes. J Neuroimmunol 1999;100:124-139.
12. Lue LF, Rydel R, Brigham EF: Inflammatory repertoire of Alzheimer's disease and nonde-mented elderly microglia in vitro. Glia 2001;35:72-79.
13. Acarin L, Gonzalez B, Castellano B: Neuronal, astroglial and microglial cytokine expression after an excitotoxic lesion in the immature rat brain. Eur J Neurosci 2000;12:3505-3520.
14. Kossmann T, Hans V, Imhof H, Trentz O, Nakamura S: Interleukin-6 released in human cerebrospinal fluid following traumatic brain injury may trigger nerve growth factor production in astrocytes. Brain Res 1996;713:143-152.
15. Kennedy MK, Torrance DS, Picha KS, Mohler KM: Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. J Immunol 1992;149:2496-2505.
16. Agrello D, Villa P, Ghezzi P: Inhibition of TNF and interleukin-6 production in the CNS of interleukin-10-deficient mice. Brain Res 2000;869:241-243.
17. Heyen R, Ye S, Fink BN, Johnson RW: Interleukin (IL)-10 inhibits IL-6 production in microglia by preventing activation of NF-kappa B. Brain Res Mol Brain Res 2000;77:138-147.
18. Maimone D, Cioni C, Rosa S, Macchia G, Aloisi F, Annunziata P: Norepinephrine and vasoactive intestinal peptide induce IL-6 secretion by astrocytes: Synergism with IL-1b and TNF-a. J Neuroimmunol 1993;47:73-82.
19. Hama T, Kushima Y, Miyamoto M, Kubota M, Takei N, Hatanaka H: Interleukin-6 improves the survival of mesencephalic catecholaminergic and septal cholinergic neurons from postnatal, one week old rats in culture. Neuroscience 1991;40:445-452.
20. Kushima Y, Hama T, Hatanaka H: Interleukin-6 as neurotrophic factor for promoting the survival of cultured catecholaminergic neurons in a chemically defined medium from fetal and postnatal rat midbrains. Neurosci Res 1992;13:267-280.
21. Navarra P, Tsagarakis S, Faria MS, Rees LH, Besser GM, Grossman AB: Interleukins-1 and -6 stimulate the release of corticotropin-releasing homone-41 from rat hypothalamus in vitro via the eicosanoid cylooxygenase pathway. Endocrinology 1991;128:37-44.
22. Kreutzberg GW: Microglia: A sensor for pathological events in the CNS. Trends Neurosci 1996;19:312-318.
23. Barron KD: The microglial cell. A historical review. J Neurol Sci 1995;134(suppl):57-68.
24. Hickey WF, Kimura H: Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science 1988;239:290-292.
25. Kuby J: Cells and organs of the immune system. In: Immunology. Anonymous. New York, Freeman, 1996, pp 47-83.
26. Hoek RM, Ruuls SR, Murphy CA, Wright GJ, Goddard R, Zurawski SM, Blom B, Homola ME, Streit WJ, Brown MH, Barclay AN, Sedgwick JD: Down-regulation of the macrophage lineage through interaction with OX2 (CD200). Science 2000;290:1768-1771.
27. Neumann H: Control of glial immune function by neurons. Glia 2001;36:191-199.
28. Morrison III B, Saatman KE, Meaney D., McKinney M: In vitro central nervous system models of mechanically induced trauma: A review. J Neurotrauma 1998;15:911-928.
29. Laplaca MC, Lee VM-Y, Thibault LE: An in vitro model of traumatic neuronal injury: Loading rate-dependent changes in acute cytosolic calcium and lactate dehydrogenase release. J Neurotrauma 1997;14:355-368.
30. Zimmer J, Kristensen BW, Jakobsen B, Nora-berg J: Excitatory amino acid neurotoxicity and modulation of glutamate receptor expression in organotypic brain slice cultures. Amino Acids 2000;19:7-21.
31. Han Y, Wu D, Xiao X, Chen PMY, Chung W, Lee N, Pang Y, Carlier PR: Protection against ischemic injury in primary cultured astrocytes of mouse cerebral cortex by bis (7)-tacrine, a novel anti-Alzheimer's agent. Neurosci Lett 200;288:95-98.
32. Shafer LL, McNulty JA, Young MRI: Brain activation of monocyte lineage cells: Brain-derived soluble factors differentially regulate BV2 microglia and peripheral macrophage immune functions. Neuroimmunomodulation 2002-03;10:283-294.
33. Gahwiler B, Capogna M, Debanne D, McKin-ney RA, Schwab ME: Organotypic slice cultures: A technique has come of age. Trends Neurosci 1997;20:471-477.
34. Czapiga M, Colton CA: Function of microglia in organotypic slice cultures. J Neurosci Res 1999;56:644-651.
35. Chang RCC, Hudson P, Wilson B, Haddon L, Hong J: Influence of neurons on lipopolysaccharide-stimulated production of nitric oxide and tumor necrosis factor-alpha by cultured glia. Brain Res 2000;853:236-244.
36. Beyer M, Gimsa U, Eyupoglu LY, Hailer NP, Nitsch R: Phagocytosis of neuronal or glial debris by microglial cells: Upregulation of MHC class II expression and multinuclear giant cell formation in vitro. Glia 2000;31:262-266.
37. Blasi E, Barluzzi R, Bocchini V, Mazzolla R, Bistoni F: Immortalization of murine microglial cells by a v-raf/v-myccarrying retrovirus. J Neuroimmunol 1990;27:229-237.
38. Bocchini V, Mazzolla R, Barluzzi R, Blasi E, Sick P, Kettenmann H: An immortalized cell line expresses properties of activated microglial cells. J Neurosci Res 1992;31:616-621.
39. Sugaya K, Chouinard M, McKinney M: Immu-nostimulation protects microglial cells from nitric oxide-mediated apoptosis. Neuroreport 1997;8:2241-2245.
40. Cox GW, Mathieson BJ, Gandino L, Blasi E, Radzioch D, Varesio L: Heterogeneity of hematopoietic cells immortalized by v-myc/v-raf recombinant retrovirus infection of bone mar1492-1496.
41. Boehm U, Guethlein L, Klamp T, Ozbek K, Schaub A, Futterer A, Pfeffer K, Howard JC: Two families of GTPases dominate the complex cellular response to IFN-gamma. J Immunol 1998;161:6715-6723.
42. Frohmann EM, Vayuvegula B, van der Noort S, Gupta S: Norepinephrine inhibits gamm-interferon-induced MHC II (Ia) antigen expression on cultured brain astrocytes. J Neuroimmunol 1988;17:89-101.
43. Melillo G, Taylor LS, Books A, Cox GW, Varesio L: Regulation of inducible nitric oxide synthase expression in IFN-Gamma treated murine macrophages cultured under hypoxic conditions. J Immunol 1996;157:2638-2644.
44. Prechel MM, Ding C, Washington RL, Kolodsiej MS, Young MRI: In vivo indomethacin treatment causes microglial activation in adult mice. Neurochem Res 2000;25:357-362.
45. Liva SM, Kahn MA, Dopp JM, De Vellis J: Signal transduction pathways induced by GM-CSF in microglia: Significance in the control of proliferation. Glia 1999;26:344-352.
46. O'Keefe GM, Nguyen VT, Benveniste EN.: Class II transactivator and class II MHC gene expression in microglia:modulation by the cytokines TGF-beta, IL-4, IL-13 and IL-10. Eur J Immunol 1999;29:1275-1285.
47. Staniek V, Misery L, Peguet-Navarro J, Abello J, Doutremepuich JD, Cloudy A, Schmitt D: Binding and in vitro modulation of human epidermal Langerhans cell functions by substance P. Arch Dermatol Res 1997;289:285-291.
48. Bell MD, Gonzalez R, Lawson L, Hughes D, Fraser I, Gordon S, Perry VH: Upregulation of the macrophage scavenger receptor in response to different forms of injury in the CNS. J Neurocytol 1994;23:605-613.
49. Giulian D, Chen J, Ingeman JE, Johnson KG, Noponen M: The role of mononuclear phagocytes in wound healing after traumatic injury to adult mammalian brain. J Neurosci 1989;9:4416-4429.
50. Das GD: Resting and reactive macrophages in the developing cerebellum: An experimental ultrastructural study. Virchows Arch B Cell Pathol 1976;20:287-298.
51. Smith ME: Phagocytosis of myelin in demyeli-native disease: A review. Neurochem Res 1999;24:261-268.
52. Acarin L, Gonzalez B, Castro AJ, Castellano B: Primary cortical glial reaction versus secondary thalamic glial response in the excitotoxically injured young brain: Microglial/macrophage response and major histocompatibility complex class I and II expression. Neuroscience 1999;89:549-565.
53. Streit WJ: Microglial-neuronal interactions. J Chem Neuroanat 1993;6:261-266.
54. Sudo S, Tanaka J, Toku K, Desaki J, Matsuda S, Arai T, Sakanaka M, Maeda N: Neurons induce the activation of microglial cells in vitro. Exp Neurol 1998;154:499-510.
55. Madden KS, Felten DL: Experimental basis for neural-immune interactions. Physiol Rev 1995;75:77-106.
56. Benveniste EN: Cytokines: Influence on glial cell gene expression and function. Chem Immunol. Basel, Karger, 1997, vol 69, pp 31-75.
57. Lemke R, Hartig W, Robner S, Bigl V, Schliebs R: Interleukin-6 is not expressed in activated microglia and in reactive astrocytes in response to lesion of rat basal forebrain cholinergic system as demonstrated by combined in situ hybridization and immunocytochemistry. J Neurosci Res 1998;51:223-236.
58. Gadient RA, Otten UH: Identification of IL-6 (IL-6)-expressing neurons in the cerebellum and hippocampus of normal adult rats. Neurosci Lett 1994;182:243-246.
59. Harir RJ, Chang VA, Barie PS, Wang RS, Sha-rif SF, Ghajar JBG: Traumatic injury induces interleukin-6 production by human astrocytes. Brain Res 1994;636:139-142.
60. Keidar S, Heinrich R, Kaplan M, Heyek T, Aviram M: Angiotensin II administration to atherosclerotic mice increases macrophage uptake of oxidized ldl: A possible role for interleukin-6. Arterioscler Thromb Vasc Biol 2001;21:1464-1469.
61. Calvo CF, Dobbertin A, Gelman M, Glowinski J, Mallat M: Identification of CSF-1 as a brain macrophage migratory activity produced by astrocytes. Glia 1998;24:180-186.
62. Barker R, Larner A: Substance P and multiple sclerosis. Med Hypotheses 1992;37:40-43.
63. Smith ME: Phagocytosis of myelin in demyelinative disease: A review. Neurochem Res 1999;24:261-268.